DADA has developed or has actively participated in the development of more than 50 generic or generic ‘plus’ products. These concern human as well as veterinary medicinal products. Although DADA has no private laboratory facilities for product development, production or analysis, we manage and monitor complete product development projects, selecting the most suitable active pharmaceutical ingredient, product development company, laboratory and production facility, and CRO for clinical studies. Of course, these procedures are fully transparent and our clients always take the final decisions. It should be emphasized that DADA has no financial interest in any of these companies, ensuring a fully objective recommendation.